Company: EDSA
Filing Date: 2025-02-13
Form Type: 8-K
Source: 0001171843-25-000796
Chunk: 9

Company: Edesa Biotech, Inc.
Filing Date: 2025-02-13
Form: 8-K
Item: Item 9.01
Chunk 9
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────
          3.1      Articles of Edesa Biotech, Inc.                                              
         10.1      Form of Securities Purchase Agreement.                                       
         10.2      Form of Investor Rights Agreement.                                           
         99.1      Press Release, dated February 13, 2025.                                      
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               Edesa Biotech, Inc.                               
  Date: February 13, 2025      By:                      /s/ Stephen Lemieux      
                               Name:                    Stephen Lemieux          
                               Title:                   Chief Financial Officer